false000082718700008271872025-03-032025-03-03

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

FORM 8-K

CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF
THE SECURITIES EXCHANGE ACT OF 1934

Date of Report (Date of earliest event reported):  March 3, 2025 
a1.jpg
SLEEP NUMBER CORPORATION
(Exact name of registrant as specified in its charter)
Minnesota
(State or other jurisdiction of incorporation)
000-2512141-1597886
(Commission File Number)(IRS Employer Identification No.)
1001 Third Avenue South, Minneapolis, MN  55404
(Address of principal executive offices) (Zip Code) 
(763) 551-7000
(Registrant’s telephone number, including area code)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
☐
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:
Title of each class Trading
Symbol(s)		 Name of each exchange on which registered
Common Stock, par value $0.01 per share SNBR Nasdaq Global Select Market

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). 
Emerging growth company  ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ☐



ITEM. 5.02DEPARTURE OF DIRECTORS OR CERTAIN OFFICERS; ELECTION OF DIRECTORS; APPOINTMENT OF CERTAIN OFFICERS; COMPENSATORY ARRANGEMENTS OF CERTAIN OFFICERS.
Appointment of Linda Findley as President, Chief Executive Officer and Director

On March 5, 2025, Sleep Number Corporation (the “Company”) announced that the Board of Directors unanimously appointed Linda Findley to the position of President and Chief Executive Officer and Board member, effective as of April 7, 2025. Ms. Findley accepted the appointment on March 3, 2025.

From 2019 to 2024, Ms. Findley, (52), served as the President, Chief Executive Officer and Director at Blue Apron Holdings, Inc. (formerly Nasdaq: APRN), an ingredient and recipe meal kit company, where she spearheaded a turnaround strategy that culminated in the company’s sale in September 2023. From 2016-2018, Ms. Findley was Chief Operating Officer at Etsy, Inc. (Nasdaq: ETSY), a global e-commerce marketplace for unique and creative goods, where she oversaw global operations, product, marketing and brand strategy, customer support, and international expansion. From 2012 to 2015, Ms. Findley held a variety of senior executive roles at Evernote Corp., a computer application corporation, including most recently as Chief Operating Officer. From 2009-2012, she led global marketing, business development, and consumer service for Alibaba.com Ltd., a technology company specializing in e-commerce and retail, based out of Hong Kong. Ms. Findley has served on the board of directors of Ralph Lauren (NYSE: RL), a designer clothing, accessories and home furnishings company, since August 2018, where she is a member of the Audit Committee and the Finance Committee, as well as Chair of the Talent, Culture and Total Rewards Committee. She holds a Master's degree in Journalism from UNC-Chapel Hill and an undergraduate degree in Corporate Communications from Elton University.

Pursuant to the terms of the Company’s offer letter dated March 3, 2025 (the "Offer Letter"), Ms. Findley will be entitled to:

•Annual base salary of $1,200,000;
•Participation in the Company's Annual Incentive Plan ("AIP") for fiscal year 2025 with a target incentive of 125% of base salary; the incentive for fiscal 2025 will be prorated based on Ms. Findley's actual eligible earnings received in the fiscal year beginning with her start date;
•Eligibility for target of $5M in annual long-term incentive awards beginning in 2026;
•A combination of long-term incentive inducement grant awards ("Inducement Grant") under Nasdaq rules with a total value of $10,000,000, which will be granted on April 15, 2025, subject to the terms of the Company's 2020 Equity Incentive Plan, as amended, and applicable Inducement Grant award agreements:
◦$5,000,000 time vested restricted stock unit ("RSU") award, vesting 33% per year on each of the first three anniversaries of the date of grant, subject to continued employment; and
◦$5,000,000 LTI award in 50% of performance stock units ("PSUs"), vesting on the third anniversary of the date of grant with the number of shares to be earned based on actual Company performance for fiscal years 2025 to 2027 vs. net sales and net operating profit goals and 50% time-vested RSU award, vesting 33% per year on each of the first three anniversaries of the date of grant, subject to continued employment;
◦The Inducement Grant will be for a number of shares of common stock of the Company with a grant value of $10,000,000, calculated using the average closing share price for the 20 trading days immediately preceding the date of the offer; provided, however, that the number of shares covered by this grant will be subject to adjustment, such that in no event will the grant have a grant date fair value (i) exceeding $11,000,000 or (ii) less than $10,000,000, in each case, calculated using the per share closing price of the Company’s common stock on the date of grant.
◦Modifications to the Inducement Grant award agreements only (not applicable to future grants)
▪Added a one-year non-compete clawback provision that is not otherwise present in award agreements for Minnesota residents; and
▪Added accelerated vesting clause providing that in the event of a qualifying termination within the first three years of employment, the PSUs will be accelerated pro rata to the termination date and RSUs pro rata to the termination date plus one year of accelerated vesting commensurate with the one year noncompete;
•Participate in the Company's Executive Severance Pay Plan (under which, upon termination of employment without cause, Ms. Findley would be entitled to severance pay equal to (a) two times the sum of (i) annual base salary and (ii) annual target incentive, plus (b) a pro rata annual incentive for the year of termination) and modified as follows:
◦Company will not modify the Executive Severance Pay Plan as to Ms. Findley in a detrimental manner for 3 years; and
◦Revised definition of “For Cause” terminations and inclusion of gross negligence standard


•$200,000 one-time relocation payment plus an additional amount based on a 40% tax rate to help cover applicable taxes for a total payment of $333,333 subject to tax withholding;
•up to $4,000 per month for temporary living and commuting expenses for up to 6 months plus applicable tax gross-up;
•Up to $15,000 reimbursement for legal fees in connection with review of the Offer Letter
•Receive the similar perquisites provided to other senior executives of the Company, including reimbursement for tax and financial planning services up to $20,000 and the ability to participate in an annual executive physical program;
•Participate in the same health and welfare benefit plans as the Company makes available to all team members. Ms. Findley will also be eligible to participate in the Sleep Number Profit Sharing and 401(k) Plan and the Sleep Number Executive Deferral Plan in accordance with the respective terms of such plans.

The foregoing description of Ms. Findley's offer letter is a summary of the material terms of the offer letter, and is qualified in its entirety by reference to the Linda Findley Offer Letter filed as Exhibit 10.1 to this Current Report on Form 8-K, which is incorporated herein by reference.

Michael J. Harrison will not stand for reelection at 2025 Annual Meeting

On March 4, 2025, Michael J. Harrison, independent Lead Director, informed the Company that he will not stand for reelection to the Board his term expires at the conclusion of the 2025 Annual Meeting. The Company thanks Mr. Harrison for his service and dedication during his tenure as a member of the Board. Mr. Harrison's decision is solely his professional decision and was not due to any disagreement with the Company on any matter related to the Company’s operations, policies or practices.

ITEM 9.01FINANCIAL STATEMENTS AND EXHIBITS.

(d) Exhibits.
Exhibit No.Description of Exhibit
10.1
99.1
104Cover Page Interactive Data File (embedded within the Inline XBRL document)


SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

  SLEEP NUMBER CORPORATION
  (Registrant)
     
Dated:  March 5, 2025 By:     /s/ Samuel R. Hellfeld
  Name: Samuel R. Hellfeld
  Title: Executive Vice President and Chief Legal and Risk Officer



Exhibit 10.1
image1.jpg
March 3, 2025

Linda Findley
(delivered electronically)


Dear Linda,

On behalf of Sleep Number Corporation, we are excited to extend the offer of employment as the President and Chief Executive Officer (CEO) reporting to Sleep Number’s Board of Directors (“Board”). Your anticipated start date will be April 7, 2025. Effective upon your start date, you will be appointed to the Board as a director with the intent that you will remain as a director during your tenure as CEO and you will be nominated for election at the Company’s 2025 Annual Shareholder Meeting.
The compensation package associated with this offer is as follows:

•Base Salary – Starting annualized salary of $1,200,000, which is payable according to Sleep Number’s payroll cycle, and subject to applicable federal and state taxes.

•Annual Incentive Plan (AIP) – You will be eligible to participate in the Sleep Number Annual Incentive Plan (AIP) for 2025 at a target incentive of 125% of eligible earnings. The actual payout will be based on the Company’s achievement of performance goals, with a maximum payout of 200% of target, subject to the Compensation Committee’s approval of the 2025 AIP (expected on February 21, 2025). For 2025, your annual incentive will be prorated based on your actual eligible earnings paid in 2025, beginning with your start date, and you will receive the same percentage of your target payout as other eligible participants.

•Long-term Incentive Plan –You will be eligible to receive annual Long-term Incentive (LTI) awards, which are typically granted on March 15th of each year. The current mix of your annual LTI award is 50% in Performance Stock Units (PSU) and 50% in time-vested Restricted Stock Units (RSU). We utilize competitive LTI guidelines to inform the annual award target and mix. You will be eligible for your annual LTI award on March 15, 2026, subject to Board of Directors’ approval. Your annual LTI award guideline will be $5,000,000.

Your offer includes a special, one-time long-term incentive grant with a total value of $10,000,000. This equity award will be for a number of shares of common stock of the Company with a targeted grant date fair value of ten million dollars ($10,000,000) calculated using the average closing share price for the 20 trading days immediately preceding the date of this offer, March 3, 2025; provided, however, that the number of shares covered by this grant will be subject to adjustment, such that in no event will the grant have a grant date fair





value (i) exceeding eleven million dollars ($11,000,000) or (ii) less than ten million dollars ($10,000,000), in each case, calculated using the per share closing price of the Company’s common stock on the date of grant. The grant date for your LTI awards will be on the 15th of the month following your start date. With an anticipated start date of April 7, 2025, the grant date would be April 15, 2025. The makeup of this award is:

•$5,000,000 time-vested Restricted Stock Unit (RSU) Award –Your RSU award will vest in three equal annual installments on each anniversary from the date of grant, subject to continued employment and the terms of the award.

•$5,000,000 LTI award in 50% Performance Stock Unit (PSU) Award and 50% time-vested Restricted Stock Units (RSU)– The PSUs will vest three years after the date of grant, subject to continued employment and the terms of the award. These stock units are subject to a performance adjustment based on the Company’s performance for the three fiscal years from 2025 to 2027 subject to the Compensation Committee’s approval of the 2025 LTI plan (expected on March 11, 2025).

The RSUs and PSUs will be issued as an “inducement grant” under the applicable rules of the Nasdaq Stock Market, and the Company will complete all required filings, including without limitation the timely filing of a Form S-8 on or before the date of the inducement grant. The specific terms and conditions for these LTI awards will be defined in applicable award agreements and plan documents.

The following is a summary of additional items included in this offer:

•You will be eligible to participate in the Sleep Number Executive Deferral Plan. This plan enables you to defer a portion of your salary, AIP payout, or PSU/RSU payouts at vesting. Your first opportunity to participate in the plan will be for 2026 deferral elections (election to be made by 12/31/2025).

•You will be eligible for the following executive perquisites which are fully taxable, and you will be responsible for any tax obligations on the imputed income amounts:
–Reimbursement for financial counseling expenses (including tax preparation and estate planning) up to $20,000 annually;
–An annual executive physical through Mayo Clinic’s Executive Health Program; and
–Covered partner travel expenses for significant other to accompany you when traveling to company events.

•You will be eligible to receive reasonable personal security services based on a review conducted by a reputable third-party consultant.

•This position qualifies you for participation in the Sleep Number Executive Severance Pay Plan, which is summarized in the Proxy Statement and included as part of the Company’s Form 10-K, highlights of which include:






–Severance: 2x annual base salary and target annual AIP and pro rata AIP incentive earned for the year based on actual performance.
–Change in Control (CIC): 3x annual base salary and target annual AIP for qualifying terminations for period 6 months prior or 2 years after a CIC event. In addition, if outstanding stock awards are assumed or substituted following a CIC event, vesting of the stock awards is accelerated in the event of involuntary termination not for cause or resignation for good reason and the termination occurs within two years of the change in control (“double trigger vesting”).

Sleep Number will not amend or modify the Executive Severance Pay Plan as it relates to you in a manner that is detrimental to you for at least three years after your employment start date. For the avoidance of doubt: (i) if your termination of employment is in connection with a “Good Reason” termination as a result of a material diminution of your base compensation, your base salary used for purposes of calculating your benefits under the Executive Severance Pay Plan will be the base salary in effect prior to such material diminution;(ii) the dispute resolution provisions set forth in the Executive Severance Pay Plan will apply to any dispute arising under that plan notwithstanding any arbitration provisions in other employment related agreements. Any release of claims required as a condition to receipt of your benefits under the Executive Severance Pay Plan will be in form and substance reasonable under the circumstances. In addition, with respect to the definition of “Cause” contained in the Executive Severance Pay Plan, the Company agrees that it shall be applied to you only in the event of the events specified in (A)-(F) thereof and modified as follows: (i) your failure to perform duties in clause (C) thereof must relate to your material duties and such failure must be grossly negligent, (ii) the violation of a Company written policy or Code of Conduct must be material and (iii) if the event is curable, you will be provided with written notice of the alleged event and the ability to cure it within 30 days of such notice (and if cured, it will no longer be an event of Cause).

•We understand that your preference is to move to Minneapolis, Minnesota as your principal residence. As such, Sleep Number shall pay a one-time Relocation Payment to cover expenses related to your relocation in the amount of $200,000 and up to six months of temporary living and commuting expenses in the amount not to exceed $4,000 per month. Sleep Number will also provide an additional amount based on a 40% tax rate to help cover taxes, if applicable. This amount shall be paid in a lump sum no later than 14 days following your start date. In the event that you voluntarily leave the Company without Good Reason during the first twenty four (24) months of employment (the “Exit Event”), you agree to re-pay Sleep Number the full amount of the Relocation Payment as follows: (i) if the Exit Event is prior to the first anniversary of your start date, you shall repay to the Company 50% of the Relocation Payment and (ii) if the Exit Event is on or after the first anniversary of your start date, but prior to the second anniversary of your Start Date, you shall repay to the Company 33% of the Relocation Payment.






•You will be eligible for a comprehensive and competitive benefits package, highlights of which include:

–Health, dental, vision, life and disability insurance
–Flexible spending and health savings accounts
–401(k) plan with a matching contribution of 100% of the first 4% of eligible compensation
–Participation in our Flex Time Off (“unlimited”) program
–Participation in our Corporate Holiday program (includes 9 days)
–Significant discount on our products including your gift of quality sleep (a free 360 p5 Smart Bed with the option to upgrade and individualize)

•We will reimburse you for up to $15,000 in legal fees incurred in connection with your review of this offer and its terms and conditions.

•As an officer and director of Sleep Number, you will be indemnified and held harmless by Sleep Number to the fullest extent permitted under Minnesota law as set forth in our articles of incorporation and bylaws.

Linda, the entire board is looking forward to building the future with you. We know you will make a significant contribution in achieving our vision to become one of the world’s most beloved brands by delivering unparalleled sleep experiences. We look forward to your acceptance of employment. Brenda and I remain available for any further discussion.

Sleep well,


/s/ Michael J. Harrison

Michael J. Harrison
Independent Lead Director on behalf of the Board




Acceptance of Offer:


/s/ Linda Findley

Linda Findley











Your appointment is subject to full Board approval, which we will seek following your acceptance of this offer.

This offer is contingent on your successful completion of a background investigation and compliance with the Immigration Reform Control Act of 1986 (IRCA). This offer is also conditional on your signing our Employee Inventions and Confidentiality Agreement and Mutual Arbitration Agreement and Code of Business Conduct.

You should understand that, except as expressly set forth herein, this offer of employment does not constitute a contract of employment, nor is it to be construed as a guarantee of continuing employment for any period of time. Employment with Sleep Number is “at will.” We recognize your right to terminate the employment relationship at any time, and for any reason, and similarly, we reserve the right to alter, modify or terminate the relationship at any time and for any reason. Except as expressly set forth herein, Sleep Number reserves the right to change the compensation plans at any time without notice.

The purpose of this letter is solely to notify you of the proposed salary and grants described above. The definitive terms of the grant will be set forth in definitive agreements that will be provided to you through the Charles Schwab website. The terms set forth in such definitive agreements will supersede the terms set forth in this letter in all respects and such definitive agreements will be the final and conclusive terms of your grant.











Exhibit 99.1
image.jpg
Sleep Number Board Names Linda Findley
as President and Chief Executive Officer

Findley has a demonstrated record of accelerating growth and transformation across diverse consumer business models

Phillip Eyler to become independent Board Chair, effective after the 2025 Annual Meeting of Shareholders

MINNEAPOLIS – (March 5, 2024) – Sleep Number Corporation (Nasdaq: SNBR) today announced that its Board of Directors (the “Board”) has appointed Linda Findley as the company’s new President and Chief Executive Officer, and as a member of the Board, effective April 7, 2025.

Findley succeeds Shelly Ibach, who previously announced her intention to retire in October 2024. Ibach will continue serving as Board Chair until the expiration of her term at the company’s 2025 Annual Meeting. The Board has unanimously appointed Phillip M. Eyler as independent Chair effective upon the conclusion of the 2025 Annual Meeting. Michael J. Harrison, who has served as the Board’s independent Lead Director since 2022, has informed the Board that he will not stand for reelection and will retire from the Board at the 2025 Annual Meeting.

Findley has extensive experience leading consumer brands that combine digital and physical products, with specific expertise in operations management, organizational transformation, and marketing strategy. Most recently, she served as CEO at Blue Apron Holdings, Inc. (formerly Nasdaq: APRN) from 2019 to 2024, where she successfully spearheaded a turnaround strategy that culminated in the company’s sale to a strategic buyer in September 2023.

Previously, Findley was Chief Operating Officer at Etsy, Inc. (Nasdaq: ETSY) where she was responsible for overseeing global operations, product, marketing and brand strategy, customer support, and international expansion. She played a pivotal role in accelerating Etsy’s sales growth, as well as advancing their global footprint and both buyer and seller experiences on the platform.

“We are excited to welcome Linda to Sleep Number as our new CEO,” said Eyler. “She will advance our ongoing transformation and guide the company into its next chapter. Her commitment to innovation and deep expertise in using technology to connect with the customer align well with our mission to improve lives through individualized sleep experiences. With a proven ability to champion change, enhance performance, drive revenue growth and build engaging brands, Linda is well-equipped to lead Sleep Number as we work to capitalize on the significant opportunity ahead of us and to deliver long-term value for our stakeholders.”

Findley’s appointment follows a rigorous search and selection process conducted by the company’s independent directors with the assistance of a leading executive search firm. Every independent director engaged with the finalists, and the Board’s decision was unanimous. Ibach recused herself from final interviews as well as the vote on her successor’s appointment.

“Millions of customers trust Sleep Number to help improve their health and wellness through a better night’s sleep,” said Findley. “It is an honor to join the team as President and CEO at this pivotal time and lead the company as we continue to advance our business transformation. I look forward to collaborating with the Board, team members and partners to unlock new opportunities for profitable growth.”

Eyler, who will succeed Ibach as Board Chair, is an accomplished public company CEO. From 2017 to 2025, he served as President and CEO of Gentherm Incorporated (“Gentherm”) (Nasdaq: THRM), where he implemented the company’s Focused Growth strategy and led the repositioning of the company’s business lines. During his tenure, the company achieved all-time highs in revenue and new business awards and expanded operating margins. Eyler remains a senior advisor to Gentherm and also currently serves on the board of Sensata Technologies Holdings plc (NYSE: ST).

“I am confident this leadership transition will position Sleep Number well for the future,” said Harrison. “With our successful CEO search process complete, and after 13 years on this Board, I have decided not to stand for reelection at the Annual

Sleep Number Board Names Linda Findley as President and Chief Executive Officer - Page 2 of 2
Meeting this year. It has been an honor to work with my colleagues on the Board, our leadership team and our team members, and I am pleased that Phil has agreed to serve as Chair after the Annual Meeting. I am excited about Sleep Number’s future under the next generation of leadership, and I look forward to seeing the company thrive as it embarks on its next chapter.”

In a separate press release today, Sleep Number also announced its fiscal fourth quarter and full year-end 2024 results.

# # #

About Linda Findley
Linda Findley, 52, served as the President, Chief Executive Officer and Director of Blue Apron Holdings, Inc. from 2019 to 2024. From 2016 to 2018, she was the Chief Operating Officer at Etsy, Inc. (“Etsy”) (Nasdaq: ETSY), where she oversaw product, design, marketing, and customer engagement and acquisition. Prior to Etsy, Ms. Findley held a variety of senior executive roles at Evernote Corp. from 2012 to 2015, including most recently as Chief Operating Officer, and led global marketing, business development, and customer service for Alibaba.com Ltd. from 2009 to 2012, based out of Hong Kong. Ms. Findley has served on the board of directors of Ralph Lauren (NYSE: RL) since August 2018. She holds a Master’s degree in Journalism from UNC-Chapel Hill and an undergraduate degree in Corporate Communications from Elon University.

About Sleep Number Corporation
Sleep Number is a wellness technology company. We are guided by our purpose to improve the health and wellbeing of society through higher quality sleep; to date, our innovations have improved nearly 16 million lives. Our wellness technology platform helps solve sleep problems, whether it’s providing individualized temperature control for each sleeper through our Climate360® smart bed or applying our 32 billion hours of longitudinal sleep data and expertise to research with global institutions.

Our smart bed ecosystem drives best-in-class engagement through dynamic, adjustable, and effortless sleep with personalized digital sleep and health insights; our millions of Smart Sleepers are loyal brand advocates. And our 3,700 mission-driven team members passionately innovate to drive value creation through our vertically integrated business model, including our exclusive direct-to-consumer selling in nearly 650 stores and online.

To learn more about life-changing, individualized sleep, visit a Sleep Number® store near you, our newsroom and investor relations sites, or SleepNumber.com.

Forward-looking Statements
Statements used in this news release relating to future plans and events such as the statements about the company’s board and leadership retirements and succession plans, its ability to advance its ongoing business transformation, unlock new opportunities for profitable growth, and deliver long-term value for our stakeholders, are forward-looking statements subject to certain risks and uncertainties which could cause the company’s results to differ materially. The most important risks and uncertainties are described in the company’s filings with the Securities and Exchange Commission, including in Item 1A of the company’s Annual Report on Form 10-K and other periodic reports. Forward-looking statements speak only as of the date they are made, and the company does not undertake any obligation to update any forward-looking statement.

Contacts
Investor Contact: Dave Schwantes; (763) 551-7498; investorrelations@sleepnumber.com
Media Contact: Julie Elepano; julie.elepano@sleepnumber.com


v3.25.0.1
Cover
Mar. 03, 2025
Cover [Abstract]  
Document Type 8-K
Document Period End Date Mar. 03, 2025
Entity Registrant Name SLEEP NUMBER CORP
Entity Central Index Key 0000827187
Amendment Flag false
Entity Incorporation, State or Country Code MN
Entity File Number 000-25121
Entity Tax Identification Number 41-1597886
Entity Address, Address Line One 1001 Third Avenue South
Entity Address, City or Town Minneapolis
Entity Address, State or Province MN
Entity Address, Postal Zip Code 55404
City Area Code 763
Local Phone Number 551-7000
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Title of 12(b) Security Common Stock, par value $0.01 per share
Trading Symbol SNBR
Security Exchange Name NASDAQ
Entity Emerging Growth Company false
Sleep Number (NASDAQ:SNBR)
Graphique Historique de l'Action
De Fév 2025 à Mar 2025 Plus de graphiques de la Bourse Sleep Number
Sleep Number (NASDAQ:SNBR)
Graphique Historique de l'Action
De Mar 2024 à Mar 2025 Plus de graphiques de la Bourse Sleep Number